Walk-Away High-Plex Proteomics to Enable Accelerated Immune Medicine

Learn about the technological innovations that can help you dramatically accelerate your immunotherapies and drug development

[wpbb post:title]
Sean Mackay, CEO and Co-Founder, IsoPlexis
  • Explore the three key IsoPlexis capabilities that enable our researchers to capture complexities connected to in vivo biology with 'walk away' automation
  • Review data & case studies across three applications: Functional Immune Landscaping, Intracellular Signaling Omics & High-plex Automated Immunoassays
2021-02-18T13:55:31-05:00